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rob.cooper@lhch.nhs.ukAbstractAlcohol septal ablation (ASA) in hypertrophic obstructive cardiomyopathy reduces left
ventricular outflow tract gradients. A third of patients do not respond; inaccurate
localisation of the iatrogenic infarct can be responsible. Transthoracic echocardiography
(TTE) using myocardial contrast can be difficult in the laboratory environment. Intra-cardiac
echocardiography (ICE) provides high-quality images. We aimed to assess ICE against TTE in
ASA. The ability of ICE and TTE to assess three key domains (mitral valve (MV) anatomy and
systolic anterior motion, visualisation of target septum, adjacent structures) was evaluated in
20 consecutive patients undergoing ASA. Two independent experts scored paired TTE and
ICE images off line for each domain in both groups. The ability to see myocardial contrast
following septal arterial injection was also assessed by the cardiologist performing ASA.
In patients undergoing ASA, ICE was superior in viewing MV anatomy (PZ0.02). TTE was
superior in assessing adjacent structures (PZ0.002). There was no difference in assessing
target septum. Myocardial contrast: ICE did not clearly identify the area of contrast in 17/19
patients due to dense acoustic shadowing (8/19) and inadequate opacification of the
myocardium (6/19). ICE only clearly localised contrast in 2/19 cases. ICE does not visualise
myocardial contrast well and therefore cannot be used to guide ASA. TTE was substantially
better at viewing myocardial contrast. There was no significant difference between ICE
and TTE in the overall ability to comment on cardiac anatomy relevant to ASA.Key Words
" hypertrophic obstructive
cardiomyopathy
" alcohol septal ablation
" non-surgical septal reduction
therapyIntroductionHypertrophic cardiomyopathy (HCM) is an inherited
disease, characterised by otherwise unexplained hypertro-
phy of the myocardium. It has an estimated phenotypic
prevalence of one in 500 (1). It is a highly heterogeneous
disease with variable penetrance and different patterns of
hypertrophy. The prevalence of left ventricular outflow
tract (LVOT) obstruction in HCM is 20–30% at rest (2) andup to 70% with provocation (3). LVOT obstruction is
associated with increased dyspnoea, a greater incidence of
stroke and higher mortality (2). Successful alcohol septal
ablation (ASA) can improve symptoms of dyspnoea and
chest pain, and may improve prognosis (4, 5, 6, 7).
Systolic anterior motion (SAM) of themitral valve (MV)
is critical to the pathophysiology of LVOT gradientwww.echorespract.com
Published by Bioscientifica Ltd
Table 1 Scoring system used to assess quality of echocardiographic images to guide ASA.
Score Observation
Mitral valve and SAM
2 Able to determine SAM – septal contact point with precision such that images could allow
determination of the length of AMVL in contact with septum at maximum excursion (or if no contact
– ability tocomment with confidence on the movement of the anterior mitral valve leaflet in systole
and diastole)
1 Able to localise approximate SAM – septal contact point (or, if there is no contact with the septum,
able to localise approximate anterior leaflet tip position at point of maximum excursion)
0 Unable to determine tip position of the anterior leaflet in relation to the interventricular septum
Target septum
2 Able to define endocardial border of basal ventricular septum in both RV and LV with visualisation of
central intra-septal ‘fusion line’ between RV and LV. On-axis images
1 Able to define endocardial border of proximal ventricular septum in both RV and LV but no
visualisation of central intra-septal ‘fusion line’ between RV and LV
0 Unable to clearly define endocardial border of one or both sides of the ventricular septum.
Other structures; RV cavity,
anterior papillary muscle,
mid-septum
2 3 key structures
1 2 key structures
0 0 or 1 key structure
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pathy (HOCM) patients. The development of significant
intra-cavity pressure is associated with severe SAM. Move-
ment of theMV apparatus towards the septum significantly
reduces LVOTarea. LVpressures then increase to eject blood
through the narrowed LVOT and maintain systemic blood
pressure, resulting in increased flow velocities through the
LVOT. This increased pressure accentuates SAM, leading
to a further reduction in LVOT area until the anterior
MV leaflet contacts the basal septum. This can initiate a
positive amplifying feedback loop resulting in significant
gradients through the LVOT (8). Interrupting this positive
amplifying feedback loop by damaging myocardium at
the SAM-septal contact area is the aim of ASA.
Failure of ASA can occur when the iatrogenic
infarct is exclusively sited in the right ventricular septal
myocardium (9, 10); the most common site for undesir-
able contrast localisation has been reported to be the RVSection A: MV
movement
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movement
Section B:
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Distant
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Figure 1
Flow chart describing method of analysis for ICE and TTE in phases 1 and 2 res
www.echorespract.comseptum andmoderator band (11). Other structures of high
importance are the mid-septum and anterior papillary
muscle as they are closely linked in vascular supply (12).
Alcohol injection these regions will not affect LVOT
haemodynamics and can be dangerous.
The procedure has been well described (13). Inter-
national guidelines recommend the use of myocardial-
contrast echocardiography (MCE) during ASA (14). MCE is
used to confirm the myocardial distribution of individual
septal vessels before injection of alcohol. Transthoracic
echocardiography (TTE) is the imaging modality of choice
for guiding ASA. There are significant difficulties in using
TTE for this procedure. The imagesmust be taken on-table,
with the patient in a supine position. There are further
logistical difficulties resulting from narrow catheterisation
tables, lack of arm support and cramped space in most
laboratories. These difficulties can result in substandard
image quality.Section A: MV
movement
Section A: MV
movement
Section B:
Target septum
Section B:
Target septum
Section C:
Distant
structures
Section C:
Distant
structures
Work view
analysis
CM
Myocardial
contrast
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All views
analysis
TTE
pectively.
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Video 1
The chosen ICE and TTE cines for all patients are presented
in sequence. Each patient has a unique identifier
‘HOCM_number’. Where the reviewers did not agree on
the best film tomaximise scores each chosen cine is shown.
These are the films used to create scores in phase 2.
Download Video 1 via http://dx.doi.org/10.1530/ERP-
15-0002-v1
R M Cooper and others Intervention in HCM: ASA ID: 15-0002; March 2015
DOI: 10.1530/ERP-15-0002In most cases, the images obtained are deemed to
be of sufficient quality to comment on the localisation of
contrast and likely alcohol distribution. However, a
significant proportion of ASA procedures fail to resolve
the LVOT gradient (6, 15, 16). This is usually due to
inaccurate location of the iatrogenic infarct (9). Sub-
standard procedural imagingmay account for the inability
to comment on highlighted territory from MCE before
alcohol injection. We must therefore consider alternative
approaches to procedural imaging.
Other echocardiographic modalities available are
trans-oesophageal echocardiography and intra-cardiac
echocardiography (ICE). ICE has been shown to provide
high-quality images in other interventional procedures
(17, 18). No sedation or anaesthetic agents are required
for the use of ICE; it is therefore an attractive modality
to guide ASA.
The aim of this study was therefore to assess the ability
of ICE to guide ASA. Our hypothesis covered two aspects of
analysis: ICE will be superior to TTE in determination of
key anatomical features required for successful ASA, and
ICE will be equivalent to TTE in localisation of myocardial
contrast.Table 2 Analysis scores for ICE vs TTE.
ICE TTE P
Work view (nZ20)
MV and SAM 1.88 (G0.28) 1.60 (G0.45) 0.02
Target septum 1.28 (G0.64) 1.08 (G0.39) 0.30
Other structures 0.63 (G0.39) 1.03 (G0.19) 0.002
All views (nZ20)
MV and SAM 1.93 (G0.18) 1.63 (G0.39) 0.007
Target septum 1.35 (G0.49) 1.10 (G0.21) 0.06
Other structures 0.85 (G0.43) 1.08 (G0.24) 0.13Methods
Study design
Before patient recruitment, a panel of experts comprising
operators familiar with ICE, TTE and ASA devised a scoring
system. This was created to directly compare the ability
of ICE and TTE to identify anatomy relevant to ASA. It is
imperative that the operator can see the movement of the
MV, the target myocardium in the septum and other key
structures (the mid-septum, anterior papillary muscle and
RV cavity) adjacent to the target myocardium. Conse-
quently, the scoring system was devised to assess each
modality in these three domains (Table 1). In addition, the
use of MCE to highlight the intended target zone was
also directly compared between the two modalities.
ICE and TTE were performed in HOCM patients under-
going ASA. Twenty consecutive patients undergoing ASA atwww.echorespract.comLiverpool Heart and Chest Hospital (LHCH) were recruited.
LHCH is a large volume centre for ASA in the UK (19).
The study was approved and supported by the
research and development board of LHCH. Patients were
informed and consented accordingly; the patient infor-
mation leaflet is available upon request.Image acquisition
ICE images were acquired by the interventional cardio-
logist performing ASA using an 8Fr AcuNav catheter
(Siemens Acuson, Mountain View, CA, USA) and VIVID Q
console (GEHealthcare,Horten,Norway),GE. The catheter
tip was inserted via the right femoral vein. This was
manipulated into the right ventricular inlet area for
image acquisition. The phased array probe was directed
to image the inter-ventricular septum; this displayed a
left ventricle long-axis view. TTE images (VIVID I, GE
Healthcare, 3Sc RS probe, GE) were acquired focussing on
the LVOT and were predominantly the parasternal long
axis (PLAX), apical five chamber and apical three chamber.
Images were acquired according to standard British
Society of Echocardiography guidelines (20). Myocardial
contrast (0.5 ml Sonovue, Bracco,HighWycombe, UK)was
injected into previously identified septal vessels. Separate
coronary injections were performed for ICE and TTE.Image analysis
Two expert reviewers experienced in the use of ICE
independently performed off-line analysis of all images.
ICE and TTE were assessed according to the pre-defined
scoring system. The scores presented are a mean of the
two reviewers. Due to the difference in appearance of
TTE and ICE images blinding to the echocardiographic
modality was not possible.
The comparison of each modality to identify relevant
anatomy using the scoring system was performed in two
pre-determined stages (see Fig. 1). In the primary analysis,11
Table 3 Phase 1; other structures visible for work view and all view analysis in both phases. The number of times each reviewer
commented a structure was visible is displayed along with a mean of observations.
ICE TTE
ICE 1 ICE 2 Mean TTE1 TTE2 Mean
Work view
Mid septum n (%) 13 14 13.5 (67.5) 20 20 20 (100)
Anterior papillary n (%) 0 1 0.5 (2.5) 0 2 1 (5)
RV cavity 17 14 15.5 (77.5) 20 20 20 (100)
All views
Mid septum n (%) 17 15 16 (80) 19 20 19.5 (97.5)
Anterior papillary n (%) 1 2 1.5 (7.5) 1 3 2 (10)
RV cavity 19 15 17 (85) 20 20 20 (100)
Table 4 Observations from ICE images following intra-
coronary contrast injection.
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‘work view’. This was a single view chosen from a standard
range of TTE and ICE images before contrast injection.
The work view was chosen by the expert reviewer as
the projection that maximised scoring according to the
pre-defined scoring system.
This was designed to mimic the approach used in ASA
as a single-contrast injection can highlight perfused
myocardium for !10 s. This only allows acquisition of a
single view in most cases. The chosen loops were recorded
anddeclared (the cines for phase 2 are available inVideo 1).
If required multiple-contrast injections can be per-
formed in ASA allowing multiple views to be obtained.
Therefore, a secondary analysis was performed allowing
reviewers to choose separate views in order to maximise
the scores for each of the three domains; MV, target
septum and other structures. This was termed ‘all views’
analysis.
Statistical analysis was performed using Stats Direct
version2.8.0.0 (Altrincham,Cheshire,UK).WeusedWilco-
xon’s signed rank test to compare the non-parametric ICE
and TTE scores.
Finally, we assessed the potential of ICE to be used in
ASA instead of TTE. ICE images were therefore acquired
before TTE. The interventional cardiologist performing
ASA was asked to comment on the ability to perform the
procedure using ICE as the sole imaging modality. This
relied on visualising relevant anatomy and highlighted
myocardium with contrast injection.Observation Incidence (nZ20)
Dense acoustic shadowing 8
Inadequate opacification of
myocardium
6
Contrast localised to distal
structures
3
Possible using just ICE 2
No injection 1Results
Analysis of scores: working view
The results are summarised in Table 2. ICE was superior
when viewing the MV and SAM, a score of 1.88 (G0.28) vs
TTE value of 1.60 (G0.45) (PZ0.02). There was nowww.echorespract.comsignificant difference in viewing target septum. The ability
of ICE to see the intra-septal fusion line was greater in this
section, but it often lost points on the inability to clearly
see the RV endocardial border. The probe was usually
positioned very close to the septum; the echo window
therefore did not include any RV cavity. TTE scored higher
when viewing other structures. The low scores were due
to the inability of both modalities to see the anterior
papillary muscle. The mid-septum and RV cavity were
visible in almost all TTE images, and in a smaller number
of ICE images (Table 3).Analysis of scores: all views
Using multiple views had a greater effect in ICE than in
TTE (Table 2). ICE remained superior at seeing theMV. The
difference in seeing target myocardium was more marked
and neared statistical significance. ICE scored better when
viewing other structures, there was now no significant
difference between modalities. The PLAX view was the
preferred TTE view from both reviewers, with a much
smaller percentage of apical views chosen.Assessment of agreement between reviewers
We examined the inter-observer difference in image
assessment between the two experts. The k statistic value12
Figure 2
(A) and (B) show ICE images. (C) and (D) show paired TTE images. (B) and (D)
are simultaneous images taken with myocardial contrast injection.
The contrast is much more vivid in TTE (D) than ICE (B).
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observations, the observed mean difference was 0.36 (95%
CI 0.29–0.43). This suggests that, on average, for each
three sets of paired score groups, there is an isolated
difference of a single point (e.g. reviewer A scores 2, 2, 1 in
the respective three sections and reviewer B scores 2, 1, 1).
This demonstrates a good clinical agreement.Figure 3
(A) and (B) show ICE images. (C) and (D) show paired TTE images. (B) and (D)
are simultaneous images taken with myocardial contrast injection. There is
significant acoustic shadowing seen following contrast injection in the ICE
image (B). There is minimal shadowing seen on TTE (D).Myocardial contrast echocardiography
The ability to comment on contrast localisation is critical
to safe and accurate ASA and was significantly better with
TTE (Table 4). In some ICE images, the contrast did not
opacify the myocardium adequately. The operator could
not confidently comment on localisation in these cases.
Contrast could be clearly seen in paired, simultaneous TTE
images (see Fig. 2). In others, the opacification was vivid,
but the acoustic shadowing was so pronounced that it was
impossible to comment on cardiac structures beyond the
contrast (see Fig. 3).
There were three examples of contrast localising to
distal structures only rather than the target area. These
patients did not receive alcohol injection. This was not
visualised on the ICE working view, but was seen on TTE.
The contrast had passed by the time the ICE catheter was
manipulated into the correct position. It is impossible towww.echorespract.comknow in these cases whether the contrast is in the correct
area and cannot be seen due to issues with the use of ICE,
or if it localised outside the target area and echocardio-
graphic window. There were only two cases in which the
procedure could potentially have been performed using
just ICE-contrast images.
We adapted frequency settings on the ICE probe to
attempt to see contrast in those cases with inadequate
opacification of myocardium. The baseline of 11 MHz was
reduced sequentially down to 5 MHz. This allowed us to
see contrast in some, but the image quality was so poor
that we were unable to relate it to relevant anatomy (see
Fig. 4). Using tissue harmonics settings (5.0/9.5 MHz) had
a similar effect.
TTE was performed very well in this section. Ulti-
mately all alcohol injections were guided by TTE as
contrast could be seen in all 19 patients without the
phenomena described in ICE.Discussion
ICE was able to see the interaction of the MV and the
target septum very well, ICE was superior to TTE in this
section. The proximity of the probe to the MV and
increased fidelity of images provided a clear, real-time13
Figure 4
(A) shows a long-axis ICE view of the left ventricle using a frequency of
11 MHz. (B) shows the same transducer position with a frequency of 5 MHz.
(C) shows a myocardial contrast injection at a frequency of 5 MHz.
Myocardial contrast is visible in the basal septum in (C), but to allow the
operator to see this a reduction in frequencies is required. This degrades
the image to the extent that it cannot be relied upon to accurately
comment on cardiac anatomy.
Figure 5
(A) shows a typical TTE PLAX echo image, the papillary muscle in view is the
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identification of target myocardium.
There was no significant difference between ICE and
TTE when viewing target myocardium in the septum. ICE
images were often unsatisfactory as we were unable to see
the RV endocardial border. The catheter seemed to lie on
the RV endocardial septal surface more often than when
used for other interventions such as patent foramen ovale
(PFO) closure. This could be due to the altered anatomy
seen inHCM.When it was possible to create space between
the catheter and the septum, the ICE images were superior
in detailing LV endocardium and intra-septal fusion line.
TTE was superior to ICE in seeing other structures.
In the HOCM population, the anterior papillary muscle
was seen only once in all of the working views that
focussed on the LVOT. The anterior displacement of
papillary muscle architecture previously described in
HCM would explain this (21). As the muscle moves
anteriorly in the LV, it moves further away from a plane
of image that incorporates the LVOT (see Fig. 5). The
proximity of the ICE catheter to the target area meant
that the echocardiographic field was more limited. The
predominant TTE work view was PLAX.
The ability to use more than one loop in the ‘all
views’ section allowed ICE to improve scores when
viewing target septum, and to achieve near parity with
TTE in seeing other structures. This requiredmanipulation
of the ICE catheter, an acquired skill that was often not
straightforward.
posterior muscle. (B) shows a typical ICE long-axis view of the left ventricle,
with both heads of the posterior muscle visible. (C) shows a three-chamber
CMR still with a papillary muscle labelled. Relational short axis CMR images
show this to be the posterior muscle (PP), the blue line represents the plane
displayed in the three chamber view in (C). The anterior muscle (AP) is out
of shot and would be very difficult to see in the same plane as the LVOT.
The same perspectives are displayed in the non-HCM heart in (E) and (F).Myocardial contrast echocardiography
Visualisation of contrast distribution is imperative to ASA.
Several problems were encountered when using ICE.www.echorespract.comContrast agents are predominantly used in TTE to opacify
the LV cavity when assessment of function is difficult.
The development of these agents has been targeted at
providing appropriate backscatter when ultrasound is
projected from several centimetres away, as is the case in
TTE. When TTE image quality is good, contrast locali-
sation can be seen well during ASA.
The technology of the Acunav ICE transducer is
similar to that of TTE, a miniaturised phased-array probe.
The major differences are the proximity to the visualised
structures and higher frequencies used. The signal pro-
cessing techniques used in modern echocardiographic
modules have previously allowed assessment of MCE in
high- and low-mechanical index settings (22). We there-
fore did not anticipate a problem visualising contrast
with ICE.14
Figure 6
(A) shows a typical ICE image taken from phase 1. It is similar projection to a
TTE four-chamber view taken from inside the RV. (C) shows a typical four
chamber view In CMR. (E) shows a short-axis cut of the same heart. The blue
line represents the cut of the LV that is shown in (C). The shaded area is the
target for ASA. The blue line clearly passes through the inferior septum,
missing the target area. (B) shows an ICE image with the true LVOT in view.
This is represented in the three-chamber cardiac magnetic resonance
(CMR) image in (D). The shaded area is the target for ASA. (F) shows the
corresponding short-axis view, the blue line this time passes through the
target myocardium in the true septum.
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contrast in some, and acoustic shadowing in others were
difficult to explain. The explanation of this phenomenon
is an area for future study. This should involve exploring
differing doses of contrast and echocardiographic
frequencies.
The images acquired with ICE alone were of sufficient
quality to progress to alcohol injection in only 2/19 (11%)
cases. The inability to see contrast with ICE means that
this modality cannot be used to guide ASA.Figure 7
Both (A) and (B) show ICE images in systole with SAM-septal contact. In
each example, the AMVL is folded back and has a bend of nearly 90. In (B),
an area of iatrogenic infarct in the mid-septum from previous ASA is seen.
The contact area for the AMVL is further basal, there is viable, contracting
myocardium in this area.Anatomical observations
Some important anatomical lessons were noted. In the
majority of ICE LV long-axis images, the focus of the
echocardiographic field was the inferior septum. Thiswww.echorespract.composition displays the LV similar to a four-chamber view
in TTE. To see appropriate target myocardium adjacent to
the LVOT, further right rotation is required on the ICE
catheter. This brings the true LVOT in to view. An example
of this is shown in Fig. 6.
A papillary muscle was often visible and interpreted
as the anterior muscle during image acquisition. A further
investigation of papillary muscle architecture using
relational images from cardiac magnetic resonance
imaging showed this to be the posterior papillary muscle
(see Fig. 5). Historically, in anatomical studies, the
posterior muscle has been described as receiving blood
supply from the right coronary system (12). It is unlikely
to be of vascular relevance when injecting contrast into
septal vessels originating from the left coronary system.
It is rare to visualise the anterior papillary muscle in the
same plane as the target septum and LVOT.
ICE images of the interaction of the anterior MV
leaflet and the septum are of such high quality that they
provide new insights. The ability to visualise the abnormal
MV anatomy was extremely clear on ICE. It has been
previously reported that the anterior mitral valve leaflet
(AMVL) is elongated in HCM (23, 24). It has been proposed
to be part of the genetically determined phenotype rather
than the effects of haemodynamic disturbance in the
LVOT (25). A long AMVL would lend itself to the
pathophysiology seen in obstruction in HCM. The extra
length results in coaptation with the posterior leaflet
towards its mid-point, leaving a redundant tip. This
redundant tip is then caught in the abnormal flow in the
LV. This is seen clearly with ICE (see Fig. 7, Video 2 and
Video 3). This redundant tip is very flexible and bends
back in to the LVOT to contact the septum.15
Video 2
The redundant tip of the mitral valve displays great
flexibility and bends back into the LVOT to contact the
septum. This is seen with great clarity on ICE films. It is this
contact that initiates the positive amplifying feedback
cycle leading to significant LVOT gradients. Download
Video 2 via http://dx.doi.org/10.1530/ERP-15-0002-v2
Video 3
An area of previous infarct is visible in themid septum. The
myocardium is thinned and akinetic. This patient had an
initial good response to alcohol ablation before a
deterioration in symptoms and gradients at 6 months.
The anterior leaflet of the MV now bends back to contact
the viable myocardium in the extreme basal septum. She
returned for repeat ASA. Download Video 3 via http://dx.
doi.org/10.1530/ERP-15-0002-v3
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as the phenomenon of contact leads to the majority of the
intra-cavity gradient formation. This can be seen in several
planes of ICE imaging and could be marked and projected
onto available software to accurately detail the contact
area in three dimensions. The damage we aim to deliver
could then be more accurate and potentially more likely
to succeed. This is an area for future study.
ICE can provide such accurate detail of myocardial
structure that a coronary wire measuring 0.014” can be
seen in target myocardium (see Fig. 8).Figure 8
The arrow points towards the coronary wire. Acoustic shadowing is also
seen. This is in the target myocardium.
www.echorespract.comICE vs TTE in haemodynamic assessment
of LVOT gradients
Earlier techniques in ASA relied on the change in LVOT
gradient during balloon occlusion to identify the correct
septal artery for alcohol injection (26). Thishasbeen largely
superseded by the introduction of myocardial contrast
echocardiography, but the improvement in LVOT gradient
can provide the operator with an additional level of
information regarding the suitability of the chosen septal
vessel. To perform correct and accurate gradient assess-
ment, Doppler echocardiography should be performed
with the cursor in line with the LVOT, any ‘off angle’
assessment can underestimate velocity and hence
gradients. ICE images of the LV are predominantly in a
long-axis view with the LVOT perpendicular to the probe,
thus underestimating velocity. It is possible to create a view
akin to a TTE three- or five-chamber, but this is often
unstable and unreliable. TTE remains the gold standard
in this respect due to its flexibility.Conclusion
ICE does not visualise myocardial contrast well and
therefore cannot be used in the assessment of myocardial
supply by septal coronary arteries during ASA. TTE was
superior to ICE in visualising myocardial contrast. There
was no significant difference between ICE and TTE in the
overall ability to determine cardiac anatomy relevant to
the performance of ASA.Declaration of interest
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